Evaluation of the Effect of Type 2 Diabetes Mellitus on the Success of Adult Pulpotomy
controlled cli
1 other identifier
interventional
70
1 country
1
Brief Summary
The aim of the present study will be directed to evaluate the clinical and radiographic success of adult pulpotomies in type 2 diabetic and non-diabetic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
December 13, 2025
CompletedFirst Posted
Study publicly available on registry
January 12, 2026
CompletedJanuary 12, 2026
December 1, 2025
12 months
December 13, 2025
December 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Outcome assessment
Assessment of outcome was done using the technique described by Zanini et al. Each patient was evaluated at different time intervals; Treatment was considered successful if there was an intact final restoration, an asymptomatic tooth, and the periapical index score was 1. Treatment was considered Uncertain if the final restoration is intact, asymptomatic tooth, and the periapical index score of 2. Treatment was considered a failure if there was not an intact final restoration, irrelevant clinical symptoms and an irrelevant periapical index score. Treatment was considered a failure if there was an intact final restoration with symptoms and an irrelevant periapical index score. * Treatment was considered a failure if there was an intact final restoration, irrelevant clinical symptoms, and the periapical index was 3 or more.
3, 6, 12 months
Study Arms (2)
diabetic
EXPERIMENTALtype 2 diabetic patients
non-diabetic
EXPERIMENTALhealthy patients
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
Moataz A AlKhawas
Cairo, 11651, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 13, 2025
First Posted
January 12, 2026
Study Start
January 1, 2023
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
January 12, 2026
Record last verified: 2025-12